BILL DIMAIO

I advise founders, family-owned businesses, executives, and investors across the Healthcare & Life Sciences (HCLS) sector as a Principal with Walden Mergers & Acquisitions, where I lead the development of the firm’s HCLS practice.

My focus is the lower middle market, with an initial emphasis on sell-side M&A advisory for privately held healthcare and life sciences companies. I help owners evaluate strategic alternatives, prepare for a transaction, understand the drivers of enterprise value, and navigate the sale process with clarity and confidence.

Before joining Walden, I spent more than two decades leading strategy, transformation, operations, governance, and value-creation initiatives within complex healthcare, life sciences, and technology organizations. My experience includes work with City of Hope, UCB, Kaiser Permanente, and Lockheed Martin, as well as involvement in large-scale strategic transactions and integrations.

That operating background shapes how I advise clients. A successful transaction is not simply a financial event. It is the culmination of years of decisions involving strategy, leadership, people, operations, technology, risk, financial performance, and organizational readiness.

At Walden, we take a collaborative and highly personal approach to M&A. We understand that owners are making decisions that affect their families, employees, customers, communities, and legacies—not merely negotiating a purchase price.

My areas of focus include:

✔ Healthcare services

✔ Physician and specialty provider organizations

✔ Healthcare technology and tech-enabled services

✔ Medical devices, diagnostics, and research services

✔ Life sciences and outsourced pharmaceutical services

✔ Strategic value creation and transaction readiness

✔ Sell-side M&A and selected buy-side advisory

I also maintain relationships with private equity firms, strategic buyers, attorneys, CPAs, wealth advisors, lenders, consultants, and other professionals who support owners before, during, and after a transaction.

For a confidential conversation about your company, strategic alternatives, acquisition goals, or long-term exit plans, please contact me through LinkedIn or at bill.dimaio@waldenma.com.

Learn more at www.waldenma.com.

I advise founders, family-owned businesses, executives, and investors across the Healthcare & Life Sciences (HCLS) sector as a Principal with Walden Mergers & Acquisitions, where I lead the development of the firm’s HCLS practice.

My focus is the lower middle market, with an initial emphasis on sell-side M&A advisory for privately held healthcare and life sciences companies. I help owners evaluate strategic alternatives, prepare for a transaction, understand the drivers of enterprise value, and navigate the sale process with clarity and confidence.

Before joining Walden, I spent more than two decades leading strategy, transformation, operations, governance, and value-creation initiatives within complex healthcare, life sciences, and technology organizations. My experience includes work with City of Hope, UCB, Kaiser Permanente, and Lockheed Martin, as well as involvement in large-scale strategic transactions and integrations.

That operating background shapes how I advise clients. A successful transaction is not simply a financial event. It is the culmination of years of decisions involving strategy, leadership, people, operations, technology, risk, financial performance, and organizational readiness.

At Walden, we take a collaborative and highly personal approach to M&A. We understand that owners are making decisions that affect their families, employees, customers, communities, and legacies—not merely negotiating a purchase price.

My areas of focus include:

✔ Healthcare services

✔ Physician and specialty provider organizations

✔ Healthcare technology and tech-enabled services

✔ Medical devices, diagnostics, and research services

✔ Life sciences and outsourced pharmaceutical services

✔ Strategic value creation and transaction readiness

✔ Sell-side M&A and selected buy-side advisory

I also maintain relationships with private equity firms, strategic buyers, attorneys, CPAs, wealth advisors, lenders, consultants, and other professionals who support owners before, during, and after a transaction.

For a confidential conversation about your company, strategic alternatives, acquisition goals, or long-term exit plans, please contact me through LinkedIn or at bill.dimaio@waldenma.com.

Learn more at www.waldenma.com.